Richard Close
Stock Analyst at Canaccord Genuity
(4.74)
# 650
Out of 4,486 analysts
625
Total ratings
52.5%
Success rate
14.1%
Average return
Main Sectors:
Stocks Rated by Richard Close
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AHCO AdaptHealth | Maintained: Buy | $16 | $10.15 | +57.64% | 28 | Jun 30, 2026 | |
| CTEV Claritev | Maintained: Buy | $32 | $31.62 | +1.20% | 2 | Jun 22, 2026 | |
| HNGE Hinge Health | Rated: Buy | $65 → $76 | $89.30 | -14.89% | 12 | Jun 15, 2026 | |
| HCAT Health Catalyst | Maintained: Buy | $2 | $2.26 | -11.31% | 32 | Jun 4, 2026 | |
| CLOV Clover Health Investments | Maintained: Buy | $3.2 → $4.2 | $5.00 | -16.00% | 28 | Jun 4, 2026 | |
| PHR Phreesia | Maintained: Buy | $22 → $16 | $10.95 | +46.12% | 23 | May 28, 2026 | |
| PRVA Privia Health Group | Maintained: Buy | $34 | $27.23 | +24.86% | 25 | May 28, 2026 | |
| PGNY Progyny | Upgraded: Buy | $19 → $30 | $30.78 | -2.53% | 19 | May 19, 2026 | |
| DOCS Doximity | Maintained: Buy | $34 → $30 | $22.74 | +31.93% | 27 | May 14, 2026 | |
| EVH Evolent Health | Maintained: Buy | $4 → $6 | $5.48 | +9.49% | 78 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $5.25 | $5.22 | +0.67% | 10 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $1 | $0.5955 | +67.93% | 20 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $11 | $10.90 | +0.92% | 8 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 → $24 | $23.00 | +4.35% | 9 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $21 → $24 | $28.45 | -15.64% | 62 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 | $9.52 | +5.04% | 75 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 | $23.81 | +26.00% | 10 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $50 → $13 | $0.0001 | n/a | 6 | Mar 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $110 | $160.08 | n/a | 1 | Feb 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $2.5 → $2 | $0.0001 | n/a | 28 | May 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $89 → $83 | $56.85 | n/a | 45 | Nov 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18 → $21 | $4.80 | n/a | 60 | Nov 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 → $24 | $21.57 | n/a | 12 | Aug 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $33 | $24.68 | n/a | 1 | Feb 22, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $135 | $169.52 | n/a | 1 | Mar 1, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $55 | $26.23 | n/a | 1 | Sep 11, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $239.71 | n/a | 1 | Nov 18, 2010 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | $20 | $8.02 | n/a | 1 | Nov 23, 2009 |
AdaptHealth
Jun 30, 2026
Maintained: Buy
Price Target: $16
Current: $10.15
Upside: +57.64%
Claritev
Jun 22, 2026
Maintained: Buy
Price Target: $32
Current: $31.62
Upside: +1.20%
Hinge Health
Jun 15, 2026
Rated: Buy
Price Target: $65 → $76
Current: $89.30
Upside: -14.89%
Health Catalyst
Jun 4, 2026
Maintained: Buy
Price Target: $2
Current: $2.26
Upside: -11.31%
Clover Health Investments
Jun 4, 2026
Maintained: Buy
Price Target: $3.2 → $4.2
Current: $5.00
Upside: -16.00%
Phreesia
May 28, 2026
Maintained: Buy
Price Target: $22 → $16
Current: $10.95
Upside: +46.12%
Privia Health Group
May 28, 2026
Maintained: Buy
Price Target: $34
Current: $27.23
Upside: +24.86%
Progyny
May 19, 2026
Upgraded: Buy
Price Target: $19 → $30
Current: $30.78
Upside: -2.53%
Doximity
May 14, 2026
Maintained: Buy
Price Target: $34 → $30
Current: $22.74
Upside: +31.93%
Evolent Health
May 12, 2026
Maintained: Buy
Price Target: $4 → $6
Current: $5.48
Upside: +9.49%
May 12, 2026
Maintained: Hold
Price Target: $5.25
Current: $5.22
Upside: +0.67%
May 12, 2026
Maintained: Hold
Price Target: $1
Current: $0.5955
Upside: +67.93%
May 8, 2026
Reiterated: Buy
Price Target: $10 → $11
Current: $10.90
Upside: +0.92%
May 8, 2026
Maintained: Buy
Price Target: $22 → $24
Current: $23.00
Upside: +4.35%
May 6, 2026
Rated: Hold
Price Target: $21 → $24
Current: $28.45
Upside: -15.64%
Apr 30, 2026
Maintained: Buy
Price Target: $10
Current: $9.52
Upside: +5.04%
Apr 30, 2026
Maintained: Buy
Price Target: $30
Current: $23.81
Upside: +26.00%
Mar 10, 2023
Maintained: Buy
Price Target: $50 → $13
Current: $0.0001
Upside: n/a
Feb 27, 2023
Maintained: Hold
Price Target: $110
Current: $160.08
Upside: n/a
May 12, 2022
Maintained: Hold
Price Target: $2.5 → $2
Current: $0.0001
Upside: n/a
Nov 19, 2021
Maintained: Hold
Price Target: $89 → $83
Current: $56.85
Upside: n/a
Nov 8, 2021
Maintained: Buy
Price Target: $18 → $21
Current: $4.80
Upside: n/a
Aug 4, 2021
Maintained: Buy
Price Target: $22 → $24
Current: $21.57
Upside: n/a
Feb 22, 2019
Maintained: Hold
Price Target: $33
Current: $24.68
Upside: n/a
Mar 1, 2018
Reiterated: Buy
Price Target: $135
Current: $169.52
Upside: n/a
Sep 11, 2013
Downgraded: Hold
Price Target: $55
Current: $26.23
Upside: n/a
Nov 18, 2010
Maintained: Hold
Price Target: n/a
Current: $239.71
Upside: n/a
Nov 23, 2009
Upgraded: Hold
Price Target: $20
Current: $8.02
Upside: n/a